10 days agoNIH Awards Linshom Medical $3.5M for Respiratory Monitoring Trial
The National Institutes of Health and National Heart, Lung, and Blood Institute awarded Linshom Medical a $3.5 million SBIR Phase 2B grant for wireless, portable respiratory monitoring development and a multi-center clinical trial. The funded project is not an open solicitation, but may create collaboration opportunities in device engineering and clinical research while testing the medical-economic value of earlier detection and intervention.
22 days agoAuchincloss and Griffith Introduce Bill to Modernize Clinical Trials
Representatives Jake Auchincloss and Morgan Griffith introduced the Faster Clinical Trials Act on October 22, 2026. The proposal would establish an FDA clinical-trial innovation center and strengthen trial networks and research infrastructure, but it identifies no solicitation, contract funding, or procurement timeline.
53 days agoNIH Grants $2.25M to Tempo Therapeutics for Innovative Wound Healing Study
The NIH has awarded a **$2.25 million** SBIR grant to **Tempo Therapeutics** for a clinical trial on their MAP™ Wound Matrix technology. This funding underscores the federal commitment to support innovative biomedical solutions aimed at improving patient outcomes in wound care, creating potential avenues for contractors specializing in advanced medical device technology.
60 days agoFDA Accelerates Drug Trials with New Expedited IND Pilot Program
The FDA has launched an Expedited IND Pilot program to enhance clinical trial timelines through strategic partnerships. By facilitating collaboration between drug sponsors and research institutions, this initiative opens new contracting opportunities for firms in clinical support services, regulatory consulting, and related fields.
156 days agoHHS OMH Unveils $3M Funding for Lupus Clinical Trials with Strong Minority Focus
The HHS Office of Minority Health has launched a $3 million funding initiative for FY 2026 to enhance inclusion in lupus clinical trials among underrepresented populations. With awards of up to $500,000, organizations are invited to submit applications by July 10, 2026, emphasizing health equity and minority health outreach.
170 days agoDARPA's RAPIID Program Aims for Shelf-Stable Blood Substitute by FY2029
DARPA's RAPIID program intends to create synthetic blood substitutes for battlefield use, targeting FDA approval by FY2029. The program seeks proposals addressing blood component development and delivery technologies, presenting a robust opportunity landscape for companies in medical innovation and regulatory compliance.
172 days agoVA Initiates MDMA-Assisted Therapy Trial for PTSD and Alcohol Use Disorder
The VA has launched a clinical trial for MDMA-assisted therapy, targeting PTSD and alcohol use disorder among Veterans. This initiative, in coordination with the FDA, presents procurement opportunities related to clinical research and mental health services.